Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack

clinical trial

Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02122718

P6099clinical trial phasephase IV clinical trialQ42825046
P17countryUnited KingdomQ145
P582end time2018-09-01
P1050medical conditionstrokeQ12202
ischemiaQ188151
cerebral infarctionQ1209150
P2899minimum age50
P1132number of participants464
P6153research siteUniversity of NottinghamQ472316
Leeds Teaching Hospitals NHS TrustQ6516115
NHS GrampianQ6954137
NHS TaysideQ6954176
The Royal London HospitalQ7374421
P1813short nameXILO-FIST
P580start time2014-05-01
P8363study typeinterventional studyQ78089383
P1476titleXanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack

Search more.